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Abstract 
A trans-alveolar approach for sinus floor elevation with subsequent placement of dental implants 
was first suggested by Tatum in 1986. Later on, Summers (1994) described a different trans-
alveolar approach using set of tapered osteotomes with increasing diameters. The trans-alveolar 
approach, also referred to as “Osteotome Sinus Floor Elevation (OSFE)”, the “Summers 
technique” or “Crestal approach” may be considered more conservative and less invasive than 
the conventional lateral window approach of sinus floor elevation. This is reflected in the fact that 
more then 9 out of 10 patients that have experienced the surgical procedure were willing to 
undergo it again.  
The main indication for trans-alveolar sinus floor elevation is reduced residual bone height, which 
does not allow standard implant placement. Contraindications for trans-alveolar sinus floor 
elevation may by intraoral contraindications, local contraindications or medical conditions.  
The surgical approach utilized over the last two decades is the technique described by Summers 
with or without minor modifications. The post-surgical care after implant placement with the 
osteotome technique is similar to the post-surgical care after standard implant placement. The 
patients are usually advised to take antibiotic prophylaxis and utilize antiseptic rinses. The main 
complications reported after performing a trans-alveolar sinus floor elevation are perforation of 
the Schneiderian membrane, occurring in 3.8% of the cases and post-operative infections 
occurring in 0.8% of the cases. Other complications reported were post-operative haemorrhage, 
nasal bleeding, blocked nose, hematomas and benign paroxysmal positional vertigo.  
It is still controversial, whether it is necessary to use grafting material to maintain the space for 
new bone formation after elevating the sinus membrane utilizing the osteotome technique. 
Positive outcomes have been reported with and without using grafting material. 
A prospective study evaluating both approaches concluded that significantly more bone gain was 
seen when grafting material was used (4.1 mm mean bone gain compared to 1.7 mm when no 
grafting material was utilized). 
In a systematic review, including 19 studies reporting on 4388 implants inserted using the trans-
alveolar sinus floor elevation technique, the 3-year implant survival rate was 92.8% (95% C.I.: 
87.4%-96.0%). Furthermore, a subject-based analysis of the same material revealed an annual 
failure rate of 3.7%. Hence, one out of ten subjects experienced implant loss over 3 years.   
Several of the included studies demonstrated that trans-alveolar sinus floor elevation was most 
predictable when the residual alveolar bone height was 5mm or more and the sinus floor anatomy 
was relatively flat.  
 
 
Introduction 
Elevation of the maxillary sinus floor was first reported by Boyne in the 1960s. Fifteen years later, 
Boyne and James (1980) described the elevation of the maxillary sinus floor in patients with large, 
pneumatized sinus cavities as a preparation for the placement of blade implants. The authors 
described a two-stage procedure, where the maxillary sinus was grafted using autogenous 
particulate iliac bone at the first stage of surgery. In the second stage of surgery, after 
approximately 3 months, the blade implants were placed and later used to support fixed or 
removable reconstructions (3). 
As implant dentistry developed, it became more evident that the posterior maxillary region was 
often limited for standard implant placement, since the residual vertical bone height was 
substantially reduce. An elevation of the maxillary sinus floor was in the treatment for solving this 
problem. Several surgical techniques have been presented for entering the sinus cavity, elevating 
the sinus membrane, and placing dental implants with or without the application of bone grafts. 
A trans-alveolar approach for sinus floor elevation, with subsequent placement of implants, 
was first suggested by Tatum in 1986 (22). A “socket former” for the selected implant size was 
used to prepare the implant site. A “green-stick fracture” of the sinus floor was accomplished by 
hand tapping the “socket former” in a vertical direction. After preparation of the implant site, a 
root- formed implant was placed and allowed to heal in a submerged manner. 
Summers (20) later described a different trans-alveolar approach, using set of tapered 
osteotomes with increasing diameters (Fig. 1). The concept intended to increase the density of 
soft, Type III and IV maxillary bone, resulting in better primary stability of inserted dental implants. 
Bone was conserved by this osteotome technique because drilling was not performed. Adjacent 
bone was compressed by pushing and tapping as the sinus membrane was elevated. Then, 
autogenous, allogenic or xenogenic grafts were added to increase the volume below the elevated 
sinus membrane.  
Today, two main techniques for sinus floor elevation for dental implant placement are in use: a 
two-stage technique with a lateral window approach, followed by implant placement after a 
healing period, and a one-stage technique using either a lateral or trans-alveolar approach. The 
trans-alveolar approach, also referred to as “Osteotome Sinus Floor Elevation (OSFE)”, the 
“Summers technique” or “Crestal approach” may be considered more conservative and less 
invasive than the conventional lateral approach of sinus floor elevation. A small osteotomy is 
performed through the alveolar crest of the edentulous ridge at the inferior border of the maxillary 
sinus.  This intrusion osteotomy elevates the sinus membrane, thus creating a “tent”.   This 
provides space for graft placement and/or blood clot formation.  It should be noted that the grafts 
are placed blindly into the space below the sinus membrane.  Hence, the main disadvantage of 
this technique is the uncertainty of possible perforations of the sinus floor (Schneiderian) 
membrane.   
 Treatment options in the posterior maxilla 
Implant placement in the posterior maxilla remains a challenge. Reduced bone volume due to 
alveolar bone resorption and pneumatization of the sinus cavity makes it more difficult to place 
implants to support a dental prosthesis. 
Several treatment options have been used in the posterior maxilla to overcome the problem of 
inadequate bone quantity. The most conservative treatment option would be to place short 
implants to avoid entering the sinus cavity. However, for the placement of short implants, there is 
still a need for at least 6 mm of residual bone height. Another way of avoiding grafting the 
maxillary sinus would be to place tilted implants mesially or distally to the sinus cavity if these 
areas have adequate bone. Furthermore, extra-long zygomatic implants may be placed in the 
lateral part of the zygomatic bone. 
However, in patients with appropriate residual bone height, augmentation of the sinus floor can 
be accomplished via the trans-alveolar approach using the osteotome technique (6, 17, 20). The 
problem of inadequate bone height can be overcome by elevating the maxillary sinus floor via the 
closed technique to provide sufficient quantity of bone for dental implant placement. 
The most invasive treatment option in the posterior maxilla is the one- or two-stage sinus floor 
elevation with a lateral approach. By mastering these different methods, most edentulous areas in 
the maxilla can by restored with implant-supported reconstructions. The concept of a shortened 
dental arch must also be kept in mind. The work of Kayser (9) has shown that patients maintained 
adequate (50–80%) chewing capacity with a premolar occlusion. 
 
Anatomy of the maxillary sinus 
The maxilla consists of various anatomic structures, including the maxillary sinus, the lateral 
nasal walls, the pterygoid plates, associated vasculature structures, and teeth. 
The maxillary sinus maintains it’s overall size while the posterior teeth remain in function. It is, 
however, well known, that the sinus expands with age, and especially when posterior teeth are 
lost. One or more septa termed “Underwood’s septa” may divide the maxillary sinus into several 
recesses. 
The overall prevalence of one or more sinus septa is between 26.5% and 31% (10, 24) and is 
most common in the area between the second premolar and first molar. Edentulous segments 
have a higher prevalence of sinus septa than dentate maxillary segments. 
The sinus is lined with respiratory epithelium (pseudo-stratified ciliated columnar epithelium) 
that covers a loose, highly vascular connective tissue. Underneath the connective tissue, 
immediately next to the bony walls of the sinus, is the periosteum. These structures (epithelium, 
connective tissue, and periosteum) are collectively referred to as the Schneiderian membrane. 
Indications and contraindications 
The main indication for maxillary sinus floor elevation utilizing a trans-alveolar approach is 
reduced residual bone height, which does not allow standard implant placement.  
Contraindications for trans-alveolar sinus floor elevation may by divided into three groups: 
intraoral contraindications, medical conditions, and local contraindications. 
The medical contraindications include: chemotherapy or radiotherapy of the head and neck 
area at the time of trans-alveolar sinus floor elevation or in the preceding 6 months depending on 
the field of radiation; immunocompromised patients; medical conditions affecting bone 
metabolism; uncontrolled diabetes; drug or alcohol abuse; patient non-compliance; and 
psychiatric conditions. Whether or not smoking is an absolute contraindication for trans-alveolar 
sinus floor elevation remains controversial. A recent systematic review (16) investigated the 
influence of smoking on survival rate of implants inserted in combination with sinus floor elevation 
utilizing the lateral approach. Five of the included studies investigated the influence of smoking, 
although not clearly defined, on implant survival after sinus floor elevation. The patients were 
divided according to their smoking status. A group of non-smokers with 2159 implants and a 
group of smokers who received 863 implants were analysed. The group of smokers had a higher 
annual failure rate (3.54%) compared with an annual failure rate of 1.86% for the non-smokers. 
However, this difference did not reach statistical significance in Possion regression analysis. In 
addition, patients with a history of inner ear complications and positional vertigo are not suitable 
for the osteotome technique. 
Alteration of the nasal–maxillary complex that interferes with normal ventilation as well as the 
mucociliary clearance of the maxillary sinus, may be a contraindication for trans-alveolar sinus 
floor elevation. However, such abnormal conditions may be clinically asymptomatic or only 
present with mild clinical symptoms. These conditions include viral, bacterial, and mycotic 
rhinosinusitis, allergic sinusitis, sinusitis caused by intra-sinus foreign bodies, and odontogenic 
sinusitis resulting from necrotic pulp tissue. All odontogenic, periapical, and radicular cysts of the 
maxillary sinus should be treated prior to sinus floor elevation. A trans-alveolar sinus floor 
elevation under any of the above conditions may disturb the fine mucociliary balance, resulting in 
mucus stasis, suprainfection or a subacute sinusitis. 
Local contraindications are inadequate residual bone height (<4-5mm) and crestal bone width 
not allowing for sufficient primary stability of the implant. In addition, oblique sinus floor (>45º 
inclination) is not suitable for the osteotome technique either (Fig. 2). The reason is the fact that 
the osteotomes first enter the sinus cavity at the lower level of an oblique sinus floor, while still 
having bone resistance on the higher level. In this situation, there is a high risk of perforating the 
sinus membrane with the sharp margin of the osteotome.  
Absolute local contraindications for sinus floor elevation are: acute sinusitis; allergic rhinitis and 
chronic recurrent sinusitis; scarred and hypofunctional mucosae; local aggressive benign tumors; 
and malignant tumors. 
Surgical techniques 
Apart from the original Summers technique, only minor modifications have been presented (4, 7, 
15, 17). The technique described in this article represents a modification of the original technique: 
• Pre-surgical patient preparation includes oral rinsing with 0.1% chlorhexidine for a period of 1 
minute. 
• Local anesthesia is administered into the buccal and palatal regions of the surgical area. 
• A mid-crestal incision with or without releasing incision is made and a full-thickness 
mucoperiosteal flap is raised. 
• With a surgical stent or a distance indicator, the implant positions are marked on the alveolar 
crest with a small round bur (#1). After locating the implant positions exactly, the opening of the 
preparations are widened with two sizes of round burs (#2 and #3) to a diameter about half a 
millimeter smaller than the implant diameter intended (Fig. 3). 
• The distance from the crestal floor of the ridge to the floor of the maxillary sinus, measured 
prior to implant site preparation on the pre-operative radiograph may, in most cases, be 
confirmed at the time of surgery by penetrating the opening of the preparation with a blunt 
periodontal probe through the soft trabecular bone (type III or IV bone) to the floor of the 
maxillary sinus. 
• After confirming the distance to the sinus floor, pilot drills with small diameters (1–1.5  mm 
smaller than the intended implant diameter) are used to prepare the implant site to a distance 
of approximately 2  mm below from the sinus floor (Fig. 4). In conditions of soft type IV bone 
and a residual bone height of 5–6 mm, there is usually no necessity to use the pilot drills. It is 
sufficient to perforate the cortical bone at the alveolar crest with the round burs. 
• The first osteotome used in the implant site is a small diameter tapered osteotome with a 
rounded tip (Fig. 5). With light malleting, the osteotome is pushed towards the compact bone of 
the sinus floor (Fig. 6). After reaching the sinus floor, the osteotome is pushed about 1 mm 
further with light malleting in order to create a “greenstick” fracture on the compact bone of the 
sinus floor. A tapered osteotome with small diameter is chosen to minimize the force needed to 
fracture the compact bone. 
• The second tapered osteotome also with a rounded tip, with a diameter slightly larger than the 
first one, is used to increase the fracture area of the sinus floor (Fig. 7). The second osteotome 
is applied to the same length as the first one. 
• The third osteotome used is a straight osteotome with a diameter of about 1–1.5  mm smaller 
than the implant to be placed (Fig. 8). Instead of using the osteotomes to fracture the sinus 
floor, it has also been propagated to use piezoelectric surgery (Fig. 9). The advantage of this 
technique is that the perforation of the sinus floor may be achieved in a more controlled way 
than with osteotomes, and the risk of membrane perforation is reduced (ref). Moreover, this 
could reduce the risk of benign paroxysmal positional vertigo. The main disadvantage of this 
technique is that it is more time consuming than malleting, especially when the cortical bone at 
the sinus floor is relatively thick.   
From this point onwards, the technique utilized in the surgical procedure depends on whether or 
not grafts will be placed. 
Implant placement without grafting material 
• Without applying grafting material, the straight osteotome, with a diameter about 1–1.5 mm 
smaller than that of the implant, will be pushed further until it penetrates the sinus floor. 
• The last osteotome to be used should have a form and diameter suitable for the implant to be 
placed. For example, for a cylindrical implant with a diameter of 4.1 mm, the last osteotome 
should be a straight osteotome with a diameter about 0.5 mm smaller than the implant 
diameter. It is important that the last osteotome only enters the preparation site once.  If 
several attempts have to be made in sites with soft bone (type III or IV), there is a risk of 
increasing the diameter of the preparation which may jeopardize good primary stability. On the 
other hand, if the last osteotome diameter is too small compared to the implant diameter, too 
much force must be used to insert the implant. By squeezing the bone, more bone trauma and 
hence, greater bone resorption will occur delaying the osseointegration process (1). It is thus 
important, especially when placing implants in sites with reduced bone volume, that a fine 
balance between good primary stability and traumatizing the bone is respected. 
• During the entire preparation, it is crucial to maintain precise control of the penetration length. 
Regular osteotomes have sharp cutting edges, thus entry into the sinus cavity increases the 
risk of membrane perforation. The final step before placing the implant is to check that the 
preparation is patent to the planned insertion depth. An osteotome with a rounded tip or a 
depth gauge with a relevant diameter is pushed to the decided length (Fig. 10). 
Implant placement with grafting materials 
• When performing the osteotome technique with grafting materials, the osteotomes are not 
supposed to enter the sinus cavity per se. Repositioned bone particles, grafting materials, and 
the trapped fluid will create a hydraulic effect moving the fractured sinus floor and the sinus 
membrane upwards. The sinus membrane is less likely to tear under this kind of pressure that 
has a fluid consistency. 
• After pushing the third osteotome up to the sinus floor and before placing of any grafting 
material, the sinus membrane must by tested for any perforations. This is tested with the 
Valsalva maneuver (nose blowing). The nostrils of the patients are compressed (Fig. 11), and 
the patient blows the nose against the resistance. If air leaks out of the implant site, the sinus 
membrane is perforated, and no grafting material should be placed into the sinus cavity. 
• If no air leaks out, the sinus membrane is intact and the preparation is filled with grafting 
material (Fig. 12). The grafting material is slowly pushed into the sinus cavity with the same 
straight third osteotome (Fig. 13). This procedure is repeated four to five times until about 0.2–
0.3 g of grafting material has been pushed into the sinus cavity below the sinus membrane (Fig. 
14). In the fourth and fifth time of applying grafting material, the tip of the osteotome may enter 
about 1 mm into the maxillary sinus cavity to test if there is resistance in the preparation site. 
• Finally, before implant placement (Fig. 15), the preparation is checked for patency, as 
mentioned before, and the Valsalva maneuver is repeated. 
To achieve good primary stability in the soft trabecular bone on the posterior maxilla implants with 
slight tapered configuration or implants with a tulip shaped neck are recommended. However, it 
must always be kept in mind, that applying too much force on the bone will result in greater bone 
resorption, delaying the osseointegration process (1).  
Post-surgical care 
The post-surgical care after the implant placement with the osteotome technique is similar to 
post-surgical care after standard implant placement. To minimize the post-operative discomfort, 
the surgical intervention should be carried out as atraumatically as possible. Precautions must be 
taken to avoid perforation of the flap and the sinus membrane. The bone should be kept moist 
during the surgery, and a tension-free primary flap closure is essential. 
In addition to the standard oral home care, antiseptic rinsing with 0.1-0.2% chlorhexidine twice 
daily for the first three weeks after surgery is recommended.  Although there are no studies 
available comparing post-surgical care with and without the use of prophylactic antiobiotics, it has 
been recommended in cases where bone substitutes were used.  The patients were advised to 
take antibiotic prophylaxis e.g. Clamoxyl® 750mg three times daily, for a period of one week.   
Furthermore, antiseptic rinses with 0.1–0.2% chlorhexidine twice daily are indicated for the first 3 
weeks after surgery. 
Complications 
When performing trans-alveolar sinus floor elevation, the risk of complications must be 
considered and the appropriate treatment foreseen. During trans-alveolar sinus floor elevation the 
intrusion osteotomy procedure elevates the sinus membrane, thus creating a “tent”. This creates 
space for the blood clot and/or grafting material. An endoscopic study has shown that the sinus 
floor can be elevated up to 5mm without perforating the membrane (5). It should be noted that the 
bone grafts are placed blindly into the space below the sinus membrane. Hence, the main 
disadvantage of this technique is the uncertainty of possible perforation of the sinus membrane. 
This constitutes the most common intra-operative complication. Presence of maxillary sinus septa 
and root apices penetrating into the sinus may increase the risk of membrane perforation. In a 
recent systematic review, addressing the trans-alveolar sinus floor elevation (21), 8 studies with 
1621 implants out of the 19 included studies presented data on the incidence of perforation of the 
Schneiderian membrane. It varied between 0 % - 21.4 %, with a mean of 3.8 %.  
Smaller perforations may be closed through the trans-alveolar preparation by using tissue fibrin 
glue. In cases of larger perforations, an access must be accomplished through a lateral window 
and barrier membranes, lamellar bone plates or suturing used either alone or in combination with 
tissue fibrin glue to close the membrane perforation. If the perforation occurs before any grafting 
material is inserted, the procedure should be aborted and a second attempt for a trans-alveolar 
sinus floor elevation may be performed 6–9 months later (23, 25).  
Post-operative infection after trans-alveolar sinus floor elevation is a rare complication. Six 
studies, with 884 implants included in the systematic review of Tan and coworkers (2008), 
reported on post-operative infection.  The incidence ranged between 0 % and 2.5 % with a mean 
of 0.8 %.  Other complications reported were post-operative hemorrhage, nasal bleeding, blocked 
nose, hematomas, and loosening of cover screws resulting in suppuration and benign paroxysmal 
positional vertigo (BPPV). The BPPV may cause a substantial stress for the patient if not correctly 
identified and properly managed (26).  No air embolism was reported in the study using hydraulic 
sinus condensing (4). 
Grafting materials 
In the original publication (22), the author did not use any grafting material to increase and 
maintain the volume of the elevated area. 
Later on, Summer (20) described the Bone-Added Osteotome Sinus Floor Elevation (BAOSFE) 
technique, frequently referred to as the “Summers technique”. Tapered osteotomes with 
increasing diameters were used to compress the bone and pushing and tapping it in a vertical 
direction as the sinus membrane was elevated. Autogenous, allogenic or xenogenic grafting 
material was added to maintain the volume below the elevated sinus membrane.   
Grafting material is added incrementally to the osteotomy site and condensed until the desired 
graft height is reached. Pressure from the osteotomes is caused by the graft material and trapped 
fluids to exert hydraulic pressure on the sinus membrane, resulting in an elevation over a greater 
area (4). A recent study (11) comparing the use of Bone-Added Osteotome Sinus Floor Elevation 
with sinus floor elevation utilizing the lateral approach concluded minimal bone resorption seen 
for both methods. The reported bone resorption was 1.35mm for the BAOSFE and 1.36mm for 
the lateral approach over a period of two years after the procedure was performed. 
From the 19 studies included in the systematic review mentioned (21), 15 of them used grafting 
material. Deproteinized bovine bone mineral (DBBM) was used in 5 studies, autogenous bone 
graft was used in 2 studies and collagen was used in another 2 studies. Five studies used 
combinations of grafts, with one study using autogenous bone graft and Bioglass®, one study 
used a combination of autogenous bone graft and DBBM, one study using autogenous bone graft 
and collagen, one study using autogenous bone graft, deminerialized freeze-dried bone allograft 
and tri-calcium phosphate, and another study using autogenous bone graft, deminerialized 
freeze-dried bone allograft and antibiotics in the graft. Various types of grafts were used in 2 
studies. Three studies performed the procedure without graft placement and one study did not 
report on the graft used.  
It is still controversial, whether or not it is necessary to apply grafting material to maintain the 
space for new bone formation after elevating the sinus membrane utilizing the trans-alveolar 
osteotome technique. 
Studies in monkeys (2) showed that implants protruding into the maxillary sinus following 
elevation of the sinus membrane without grafting material, exhibited spontaneous bone formation 
over more than half of the implant’s height. Hence, protrusion of an implant into the maxillary 
sinus does not appear to be an indication for bone grafting. In the same study, it was also seen 
that the design of the implant influenced the amount of spontaneous bone formation. Implants 
with open apices or deep-threaded configurations did not reveal substantial amounts of new bone 
formation. On the other hand, implants with rounded apices tended to show spontaneous bone 
formation extending all around the implants if they only penetrated 2–3 mm into the maxillary 
sinus. However, when the same implants penetrated 5 mm into the maxillary sinus, only a partial 
(50%) growth of new bone was seen towards the apex of the implant. 
A recent clinical study (13) reported similar clinical results. The authors reported on twenty-five 
10mm dental implants inserted using the trans-alveolar approach without grafting material. The 
implants protruded on average 4.9 ± 1.9mm into the sinus cavity after surgery. After a follow-up 
time of 5 years the implant protrusion was reduced to 1.5 ± 0.9 mm. Hence 3.4mm or 70% of the 
penetrating part of the implants showed spontaneous bone formation. 
In a clinical study (12), implants were installed into the sinuses of 40 patients using the trans-
alveolar technique with no graft or cushion material. The authors reported a mean gain of alveolar 
bone height in scanned panoramic radiographs of 3.9 ± 1.9 mm.  
In a retrospective study, assessing radiographically sinus floor remodeling after implant insertion 
using a modified trans-alveolar technique without grafting material (18), twenty-four patients were 
available for follow-up. Implant survival rate was 100%. Bone filling around the implants was 
measured and compared with baseline digital radiographs. The mean height of the newly formed 
bone was 2.2 ± 1.7 mm mesially and 2.5 ± 1.5 mm distally, or, 86.3 ± 22.1% and 89.7 ± 13.3% of 
new bone formation, respectively.  
In a prospective study (14), 252 implants were inserted using the trans-alveolar sinus floor 
elevation technique with or without grafting material.  For 35% of these implants, deproteinized 
bovine bone mineral of particle size of 0.25 -1mm was used as grafting material, but for the 
remaining 164 implants, no grafting material was utilized.  Periapical radiographs were made with 
a paralleling technique and digitized. Two investigators, that were blinded to whether grafting 
material was used or not, subsequently evaluated the pattern of tissue remodeling. The mean 
radiographic bone gain using the trans-alveolar technique with grafting material was significantly 
more or 4.1 mm (SD 2.4 mm) compared with a mean bone gain of 1.7 mm (SD 2.0 mm) when no 
grafting material was used (Fig. 16a, b). 
Success and implant survival 
A recent systematic review (21) analyzed the survival and complication rates of implants inserted 
in combination with trans-alveolar sinus floor elevation. An electronic search was conducted to 
identify prospective and retrospective cohort studies on trans-alveolar sinus floor elevation, with a 
mean follow-up time of at least 1 year after functional loading. The search provided 849 titles. 
Full-text analysis was performed for 176 articles resulting in 19 studies meeting the inclusion 
criteria. Meta-analysis of these studies indicated an estimated annual failure rate of 2.48% (95 
percent confidence interval (95% C.I.: 1.37%-4.49%) translating to an estimated survival rate of 
92.8% (95% C.I.: 87.4%-96.0%) for implants placed in trans-alveolarly augmented sinuses, after 
3 years in function (Table 1).  Furthermore, subject-based analysis revealed an estimated annual 
failure of 3.71% (95% C.I.: 1.21%-11.38%), translating to 10.5% (95% C.I.: 3.6%-28.9%) of the 
subjects experiencing implant loss over 3 years.   
 
 
Residual bone height 
 
Of the 900 patient records that were screened for the Consensus Conference in 1996, only 100 
had radiographs of adequate quality for analysis of the residual bone height. In total, only 145 
sinus grafts in 100 patients, with 349 implants, were analyzed regarding the residual bone height. 
After a mean follow-up period of 3.2 years, 20 implants were lost. Of the implants lost, 13 were 
initially placed in residual bone with a height 4 mm, seven were placed in residual bone with a 
height of 5–8mm. None of the implants placed in residual bone height of more than 8mm was lost. 
There was a statistically significant difference in implant loss when residual bone height was 4mm 
or less as compared to 5mm or greater (8). Hence, for implants placed in combination with sinus 
floor elevation using the lateral approach to add to the residual bone height plays a significant 
role in implant survival. 
It is also evident that failure rate of the implants placed into sites with trans-alveolar sinus floor 
augmentation increases and correlates with reduced residual bone height and reduced implant 
length, as described in a multicenter retrospective study (17) that reported a survival rate of 96 %, 
when residual bone height was 5 mm or more.  It decreased to 85.7 %, when residual bone 
height was 4 mm or less. Similar results were also reported in a recent prospective study (15) 
were 20% of the implants in the present study were placed in sites with residual bone height of ≤ 
5 mm. This, in turn, means that the limit of the osteotome technique has indeed been tested. The 
survival rates were 91.3% for implant sites with ≤ 4mm residual bone height and 90% for sites 
with residual bone height between 4 and 5mm, compared with a survival rate of 100% if the 
residual bone height was above 5mm. Moreover, for short 6 mm implants, the survival rate was 
only 48%. This clearly demonstrated that the trans-alveolar sinus floor elevation technique was 
most predictable with residual alveolar bone height of 5mm or more and with implants of 8mm or 
more.  
 
Patient-centered outcomes 
In the study of Pjetursson and coworkers (15), 163 patients were examined at the follow-up visit 
and asked to express their opinion about 9 statements related to the treatment. The first two 
statements dealt with general satisfaction with the treatment. The patients were asked if they 
would undergo similar treatment again if needed; On the Visual Analog Scale (VAS), the mean 
VAS score was 91±17. The median was 98 (range 0-100). The patients were also asked if they 
would recommend this treatment to a friend or relative, if indicated. On the VAS, the mean VAS 
score was 90±17. The median was 97 (range 0-100). For both statements only 5 or 3 % of the 
patients would not be willing to undergo such a treatment again, respectively. 
Approximately 23 % of the patients found the surgical experience unpleasant. When asked about 
other surgical complications, 5 % of the patients felt their head was tilted too far back during the 
surgery, 5 % of the patients experienced vertigo, nausea and felt disoriented after the surgical 
procedure, but no patient had any problem with unusual eye movements. A small group of 5 
patients had psychological problems after the treatment and had to seek medical assistance (15). 
The authors concluded that even though 23% of the patients reported the surgical procedure as 
unpleasant, more than 90% of the patients were be willing to undergo implant therapy again if 
necessary and dentally indicated. 
 
Research recommendations 
The present systematic review revealed several shortcomings in the clinical studies.  Many of the 
studies on the survival of implants placed in sinus grafted sites failed to report the original 
residual bone height and graft failures, if any.   
There is a need for long-term clinical trial (≥ 5 years) of implants inserted in combination with 
trans-alveolar sinus floor elevation. However, the question, whether different surgical techniques, 
implant types, and grafting materials would improve the outcomes, remains open and future 
research is needed. Randomized controlled clinical trials with sufficient statistical power 
comparing trans-alveolar sinus floor elevations with and without grafting materials would be of 
great value.  
Conclusions and clinical suggestions 
In the posterior maxilla, implants with morphometry designed to achieve high initial stability and 
with rough surface geometry giving high percentage of bone-to-implant contact during initial 
healing phase (1), should be preferred. Implants with slightly conical morphometry or implants 
with wider implant neck tend to give better primary stability in case of reduced residual bone 
height and soft bone geometry. 
The clinical decision on which method (short implants, osteotome technique or lateral 
approach) should be chosen, depends on the residual bone height of the alveolar crest and on 
the surgeons’ preferences. The following recommendations are suggested: 
1. Residual bone height of 8 mm or more and flat sinus floor: standard implant placement 
installing relatively short implants. 
2. Residual bone height of 8 mm or more and oblique sinus floor: standard implant placement 
using short implant or elevation of the maxillary sinus floor using the osteotome technique 
without grafting material. 
3. Residual bone height of 5–7 mm and flat sinus floor: elevation of the maxillary sinus floor using 
the osteotome technique with grafting material that is resistant to resorption (Fig. 17). 
4. Residual bone height of 5–7 mm and oblique sinus floor: elevation of the maxillary sinus floor 
using lateral approach with grafting material, and simultaneous implant placement (one-stage) 
5. Residual bone height of 3–4 mm and flat or oblique sinus floor: elevation of the maxillary sinus 
floor using lateral approach with grafting material, and simultaneous implant placement (one-
stage). 
6. Residual bone height of 1–2 mm and flat or oblique sinus floor: elevation of the maxillary sinus 
floor using lateral approach with grafting material and delayed implant placement 4–8 months 
later (two-stage). 
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Legends 
 
Fig. 1 - In 1994, Summers introduced a set of tapered osteotomes with different diameters to 
compress and push the residual bone from the implant preparation into the sinus cavity and to 
elevate the sinus membrane. 
  
Fig.  2 - The oblique inferior border of the maxillary sinus lies at approximately 60º to the inferior 
border of the alveolar crest (the dotted lines represent the outlines of the residual bone).  In a 
clinical situation like this, it is difficult to elevate the maxillary sinus floor with osteotomes.  The 
osteotomes will first enter the sinus cavity distally at the lowest level of oblique sinus floor while 
still having bone resistance on the cranial level of the sinus floor.  Hence, the risk of the sharp 
margin perforating the sinus membrane is high. 
 
Fig. 3 - The exact position of the implant site is first marked with a small round bur (#1) and then 
extended with two sizes of round burs (#2 and #3) to a diameter about 0.5–1 mm smaller than 
that of the implant to be installed. 
 
Fig. 4 - The implant site is prepared to a distance of approximately 2 mm below the sinus floor 
with a small diameter pilot drill. 
 
Fig. 5 - The first osteotome used in the implant site is a small-diameter tapered osteotome.  Such 
an osteotome is chosen to minimize the force needed to fracture the compact bone. 
 
Fig. 6 - After reaching the sinus floor, the osteotome is pushed approximately 1 mm further with 
light malleting in order to create a “greenstick” fracture on the compact bone of the sinus floor. 
 
Fig. 7 - A second osteotome, which is also tapered, but with a diameter slightly larger then the 
first one, is used to increase the fractured area of the sinus floor. 
 
Fig. 8 - The last osteotome to be used must have a form and diameter suitable for the implant to 
be placed.  For example, for a cylindrical implant with a diameter of 4.1 mm, the last osteotome 
should be straight with a diameter approximately 0.5 mm smaller than that of the implant. It is 
important that the last osteotome is allowed to enter the preparation site only once. 
 
Fig. 9 - A kit of diamante coated insertion tips for piezosurgery that can be used to prepare the 
implant site and to trim down or perforated the cortical bone at the lower border of the maxillary 
sinus. 
 Fig. 10 - The final step before placing the implant is to check that the preparation is patent to the 
planned insertion depth.  Osteotome with a rounded tip or a depth gauge, for the relevant implant 
diameter, is pushed to the decided length. 
 
Fig. 11 – To test the sinus membrane for perforations, the nostrils of the patients are compressed 
and the patient is asked to blow his nose. If air leaks out of the implant site, the sinus membrane 
is perforated, and no grafting material should be placed into the sinus cavity. 
  
Fig. 12 - If the sinus membrane is intact, the preparation site is filled four to five times with 
grafting material. 
 
Fig. 13 - The grafting material is then slowly pushed into the sinus cavity with a straight 
osteotome with a diameter about 1–1.5 mm smaller than that of the intended implant size. 
 
Fig. 14 - Grafting material is slowly pushed into the sinus cavity with a straight osteotome. The tip 
of the osteotome is only supposed to enter the sinus cavity after some grafting material has been 
pushed through the preparation site to elevate the sinus membrane. 
 
Fig. 15 - A rough-textured implant was installed after preparing the implant site with the 
osteotome technique. To achieve good primary stability implants with slight tapered configuration 
or implants with a tulip shaped neck are recommended. 
 
Fig. 16 - (a) A radiograph, taken at the 5-year follow-up visit, of an implant placed in the 1st 
quadrant utilizing the osteotome technique without grafting material  A new cortical bony plate at 
the inferior border of the maxillary sinus is clearly visible, but no bony structure can be detected 
apical to the implant  (b) A radiograph (same patient) of an implant placed in the 2nd quadrant 
utilizing the osteotome technique with xenograft grafting material, taken after 5 years in function  
A dome-shaped structure is clearly visible documenting a definite increase in bone volume 
compared to the initial situation  The “dome” is surrounded with a new cortical bony plate  
 
Fig. 17 -  The ideal indication for the trans-alveolar sinus floor elevations are sites with residual 
bone height of 5-7mm and relatively flat sinus floor anatomy.  The radiograph, taken after implant 
placement, showing a dome-shape configuration of the graft.  In this instance, 0.25  g of grafting 
material (xenograft) was used to elevate the sinus membrane (the dotted lines represent the 
outlines of the residual bone)  
 
